SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-14-020749
Filing Date
2014-04-04
Accepted
2014-04-04 12:47:05
Documents
1
Group Members
DR. JAMES I. HEALYDR. MICHAEL F. POWELLERIC P. BUATOISSOFINNOVA MANAGEMENT VII, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v373922_sc13da.htm SC 13D/A 118019
  Complete submission text file 0001144204-14-020749.txt   119714
Mailing Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025
Business Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025 650-681-8420
SOFINNOVA VENTURE PARTNERS VII L P (Filed by) CIK: 0001380734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86923 | Film No.: 14745143
SIC: 2834 Pharmaceutical Preparations